Predicting treatment risk using geriatric assessment and genetic profiling for AML may impact early rates of mortality among patients aged 60 years or older. Geriatric assessment showed a high rate of ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. AI, and especially agentic AI tools, are evolving at a rapid speed, with the use of AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback